Phosphodiesterase inhibitors. Part 3: Design, synthesis and structure–activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-dihydropyridazinones with anti-inflammatory and bronchodilatory activity-Reference-Cited by-同舟云学术

Phosphodiesterase inhibitors. Part 3: Design, synthesis and structure–activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-dihydropyridazinones with anti-inflammatory and bronchodilatory activity

Published:2012-03 Issue:5 Volume:20 Page:1644-1658
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Ochiai Koji,Takita Satoshi,Eiraku Tomohiko,Kojima Akihiko,Iwase Kazuhiko,Kishi Tetsuya,Fukuchi Kazunori,Yasue Tokutaro,Adams David R.,Allcock Robert W.,Jiang Zhong,Kohno Yasushi

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference51 articles.

1. A Holy Grail of asthma management: toward understanding how long-acting β2-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids

2. Combination therapy in asthma -fixed or variable dosing in different patients?

3. Interactions between Corticosteroids and 2-Agonists in Asthma and Chronic Obstructive Pulmonary Disease

4. Combination Therapy of Inhaled Corticosteroids and Long-Acting β2- Adrenergics In Management of Patients with Chronic Obstructive Pulmonary Disease

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes;International Journal of Molecular Sciences;2023-07-15

2. One-pot synthesis of 2,6-diaryl-4,5-dihydropyridazin-3(2H)-ones: Copper catalyzed annulation of aldehydes, arylhydrazines and 3-acryloyloxazolidin-2-one;Tetrahedron Letters;2023-05

3. Synthesis and In-Vitro Antimycobacterial Evaluation of 4-Arylidene-2-Phenyl-6-(Aryl)-4,5-Dihydropyridazin-3(2H)-One Derivatives;Pharmaceutical Chemistry Journal;2023-05

4. Advances in the development of phosphodiesterase-4 inhibitors;European Journal of Medicinal Chemistry;2023-03

5. Synthesis of 3-substituted 2-trifluomethyl imidazo[1,2-a]pyridine through [3+2] cycloaddition of pyridinium ylide with trifluoroacetonitrile;Tetrahedron Letters;2022-11